Arun P. Khazanchi, MD, has been recognized as a 2024 Castle Connolly Top Doctor — the 10th year he has received the prestigious Top Doctor honor.

LAKEWOOD RANCH, FL, February 01, 2024 /24-7PressRelease/ — Arun P. Khazanchi, MD, has been recognized as a 2024 Castle Connolly Top Doctor — the 10th year he has received the prestigious Top Doctor honor. Only about 7 percent of the nation’s licensed physicians are selected annually as Castle Connolly Top Doctors in their regions for their specialties.

“Dr. K” to many, Dr. Khazanchi is a gastroenterologist with Premiere GI, where he diagnoses and treats gastrointestinal conditions that include acid reflux, irritable bowel syndrome, Crohn’s disease, inflammatory bowel disease, hemorrhoids, Barrett’s esophagus, ulcerative colitis, diverticulitis, and colon polyps.

He has special expertise in managing gallbladder and biliary (bile duct) issues, such as gallstones, cholecystitis, biliary dyskinesia, gangrene, gallbladder cancer, cholangiopathy, jaundice, and pancreatitis highlights his proficiency in his field.

Dr. Khazanchi is certified by the American Board of Internal Medicine, with subspecialty certification in gastroenterology and hepatology.

He performs procedures — many minimally invasive — that include upper GI endoscopy, colonoscopy, capsule endoscopy, endoscopic ultrasonography, endoscopic retrograde cholangiopancreatography (ERCP), esophageal dilation, and flexible sigmoidoscopy.

Dr. Khazanchi is one of the region’s few doctors who takes tissue samples (biopsies) to diagnose conditions of the rectum, lungs, pancreas, and esophagus.

With more than 20 years of gastroenterology experience, patients can have confidence in the care they receive from Dr. K.

“We keep patient care as a number one priority by providing specialized and personalized medicine to each patient by focusing on their overall health and wellness,” he says.

Dr. Khazanchi was instrumental in the founding of Florida Digestive Health Specialists, LLP (FDHS), one of the largest gastroenterology groups in southwest Florida, and served as the president and co-CEO of that group for over 10 years.

In addition to his clinical responsibilities, Dr. Khazanchi serves as an associate clinical professor of medicine at Florida State University College of Medicine. He has also been the principal investigator on more than 30 liver studies — along with producing associated publications — from 2020 to 2022. His involvement as the principal investigator for clinical trials focused on semaglutide for NASH and weight loss — as well as trials related to Crohn’s disease, ulcerative colitis, and celiac disease — shows his dedication to advancing medical research and improving treatment options for patients with these conditions.

Dr. Khazanchi earned his medical degree at St. George’s School of Medicine in Grenada, West Indies. He completed three years of internal medicine training as well as a three-year fellowship in gastroenterology and hepatology (Digestive Health Institute of Philadelphia) at The Medical College of Pennsylvania/Hahnemann University Hospital and the University of Montreal.

He also holds both MS and BS degrees — in molecular genetics and biology, respectively — from the University of Houston.

Top Doctors are nominated by peer physicians and selected by the physician-led Castle Connolly research team.

“Being nominated shows the trust, respect, and collaboration between colleagues,” Dr. Khazanchi says.

Dr. Khazanchi is affiliated with Lakewood Ranch Medical Center, Sarasota Memorial Hospital, and HCA Florida Sarasota Doctors Hospital.

About Castle Connolly
Castle Connolly publishes its Top Doctors list at and in a variety of print and online partner publications. Nominations are open to all board-certified MDs, DOs, and DPMs. The Castle Connolly team chooses honorees based on nominee criteria that includes their medical education, training, hospital appointments, and disciplinary histories.

Doctors do not and cannot pay to be selected as a Castle Connolly Top Doctor.

For the original version of this press release, please visit here